当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
David Maryam
Body dysmorphic jumble (BDD), otherwise called dysmorphophobia, is a serious mental issue that happens all over the planet. In any case, the finding is typically missed in clinical settings. It is essential to perceive and analyze BDD, on the grounds that this issue is generally normal and causes critical misery and hindrance in working. It is likewise connected with extraordinarily low quality of life. In spite of the fact that examination on viable treatment is as yet restricted, serotonin reuptake inhibitors (SRIs) are right now thought to be the medicine treatment of decision. For side effects to improve, a moderately high SRI portion and somewhere around 12 weeks of treatment is regularly required. The psychosocial treatment of decision is mental social treatment, comprising of components like openness, reaction avoidance, conduct tests, and mental rebuilding. Despite the fact that information on BDD is quickly expanding, further exploration is required on all parts of this issue, including treatment studies, the study of disease transmission studies, and examination of its culturally diverse highlights and pathogenesis.